22 results about "Meter dose inhaler" patented technology

An improved stem block for an inhaler that is fired in an upright orientation, providing easier and more reliable delivery of aerosols. The disclosed stem block demonstrates atomization efficiency that is superior to the performance of a conventional metered dose inhaler. The stem block has a passage that connects to a narrower expansion chamber. The expansion chamber connects to an exit orifice that is narrower than the expansion chamber. The exit orifice further connects to a conical outlet for dispensing an aerosol. The passage, the expansion chamber, and the exit orifice are axially aligned.

An electronic module for a metered dose inhaler comprises a housing (10) having a front wall (13) configured to face a rear side (6a) of a housing (6) of the metered dose inhaler (2), a rear wall (16) opposite the front wall (13), and a side wall (17) extending between the front wall (13) and the rear wall (16). An electronics unit (11) is mounted inside the housing (10) and comprises a capacitive proximity device (29) with a capacitive sensor antenna (30). The capacitive sensor antenna (30) is disposed against or near an inner surface of a rear wall (16) and / or a side wall (17) of the housing (10).

The present invention relates to a device (20) for delivering a medicament (30) to a user via the nasal or pulmonary route. The device may be a pressurized metered dose inhaler (200), an active dry powder inhaler (300 / 400), a soft mist inhaler (500), or a nebulizer (600). The device (20) comprises a propellant energy source (40) for delivering the medicament (30), the propellant energy source (40) being or comprising an atmospheric gas (41) stored in a canister (45) separate from the medicament, adsorbed on an adsorbate (42) at a pressure of at least 2 bar, the atmospheric gas being released from the canister to dispense the medicament (30). The device includes a gas delivery mechanism (50) having a metering chamber (52) that has a greater capacity than a conventional pressurized metered dose inhaler filled with HFC propellant. The atmospheric-like gas (41), upon actuation, is released from the chamber and travels along the conduit (25) to displace a dose of medicament (30) from the dose chamber (80) undergoing aerosolization and exit the device as a plume (60) via a second conduit (27) and an outlet (28).

The present invention generally relates to pharmaceutical composition comprising a LABA agent, optionally in combination with other active ingredients, a mixture of an acid and a chelating agent, a propellant and a co-solvent. The invention also provides a pharmaceutical composition for the treatment of respiratory diseases, such as asthma and COPD.

A metered dose inhaler comprising: a metering valve; a canister; and an actuator comprising an actuator nozzle; wherein the canister comprises a formulation, the formulation comprising greater than 70% by weight of HFO-1234ze(E); and at least one active pharmaceutical ingredient suspended in the formulation; wherein the metered dose inhaler delivers at least 0.5 milligram (mg) of the at least one active pharmaceutical ingredient per actuation. A metered dose inhaler comprising: a metering valve; a canister; and an actuator comprising an actuator nozzle; wherein the canister comprises a formulation, the formulation comprising greater than 70% by weight of HF A-152a; and at least one active pharmaceutical ingredient suspended in the formulation; wherein the metered dose inhaler delivers at least 0.5 milligram (mg) of the at least one active pharmaceutical ingredient per actuation.

The invention relates to metered dose inhaler comprising a stable pharmaceutical composition of fluticasone or its pharmaceutically acceptable ester contained in a canister fitted with a metering valve, an actuator and dose counter. The invention also relates to a process for preparing said pharmaceutical composition and its use in the treatment of respiratory disorders such as asthma in a subject (e.g., a human).

The present disclosure discloses an aerosol actuator and a metered dose inhaler. The aerosol actuator comprises a housing and a counting unit; the housing comprises a housing body and a nozzle, the housing body being configured to communicate with the nozzle; the housing body being configured to accommodate the counting unit; the counting unit comprises a gear fixing member, a counting gear, a driving element, and an elastic member; a cavity is formed inside the gear fixing member; the counting gear is arranged in the cavity; the gear fixing member comprises a cover plate part, the cover plate part comprising a cover plate part body and a check pawl; a surface of the counting gear that is close to the cover plate part body is provided with a limiting recess; the check pawl is arranged on the cover plate part body, and the check pawl is configured to coordinate with a meshing tooth of the counting gear so as to limit a rotation direction of the counting gear; the check pawl is provided with a limiting protrusion, the limiting protrusion being configured to coordinate with the limiting recess so as to limit a rotation direction of the counting gear. The aerosol actuator enables the counting to be more accurate.

An inspection unit for cans (11), in particular for metal cans used in metered dose inhalers or for the manufacture of batteries, comprising a visual inspection unit (9) comprising camera units (20), a conveying unit (8), wherein images of the individual cans are captureable by different camera units from different viewing angles, wherein the camera units each capture a plurality of cans simultaneously in an image comprising a plurality of image portions (24) including images of an outer surface portion of each of said plurality of cans from a different viewing angle, the image portions including images of outer side surface portions (22) and the outer bottom surface portion (19) of each can, the sum of the images of the outer side surface portions covering the entire outer side surface of the can; and a processing unit to process the captured images portions and to determine an inspection result.

Various embodiments of a metered dose inhaler are disclosed. The inhaler includes a metering valve, a canister, and an actuator having an actuator nozzle. The canister includes a formulation having a propellant including HFO-1234ze(E), at least 1% of ethanol by weight, and one or more cannabinoids, wherein the one or more cannabinoids is dissolved in the formulation to form a solution. In one or more embodiments, the cannabinoid includes tetrahydrocannabinol (THC) and / or cannabidiol (CBD).

A pressurised metered dose inhaler 200, an active dry powder inhaler, a soft mist inhaler or a nebuliser comprising a device 20 comprising canister walls 23 and an end face 24. The inhaler comprises a

The present invention relates to a metered dose inhaler device comprising a stable inhalable composition of ipratropium bromide, contained in a canister fitted with a metering valve, an actuator and a dose indicator. The present invention also relates to a process for preparing such a pharmaceutical composition and its use in the treatment of respiratory disorders such as for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema in a subject in need thereof (e.g., a human).

Various embodiments of a metered dose inhaler are disclosed. The inhaler includes a metering valve, a canister, and an actuator having an actuator nozzle. The canister contains a formulation having a propellant including HFA-152a, at least 1% by weight ethanol, and one or more cannabinoids, the one or more cannabinoids dissolved in the formulation to form a solution. In one or more embodiments, the cannabinoids include tetrahydrocannabinol (THC) and / or cannabidiol (CBD).

Various embodiments of a metered dose inhaler are disclosed. The inhaler includes a metering valve, a canister, and an actuator having an actuator nozzle. The canister includes a formulation having a propellant including HFA-152a, at least 1% of ethanol by weight, and one or more cannabinoids, wherein the one or more cannabinoids is dissolved in the formulation to form a solution. In one or more embodiments, the cannabinoid includes tetrahydrocannabinol (THC) and / or cannabidiol (CBD).

Pharmaceutical aerosol formulations containing pre-micronized albuterol sulfate, high amount of green propellant trans-1,3,3,3-tetrafluoropropene (HFO-1234ze (E)), and a surfactant (polysorbate 80 (polyoxyethylene (20) sorbitan monooleate), polysorbate 20 (polyoxyethylene (20) sorbitan monolaurate), polyethylene glycol 1000, span 85 (sorbitan trioleate), polyvinylpyrrolidone K25, or their combination) in a pressurized metered dose inhaler are described. The formulations do not use any co-solvent, i.e., they are co-solvent-free (e.g., free of ethanol, glycerol, propylene glycol, and a combination thereof). The formulations provide highly efficient delivery, through metered dose inhaler (MDI), of pre-micronized albuterol particles into the patients' respiratory tracts and have the advantages of high efficacy, improved safety, and a low global warming potential (GWP) for environmental impact.

The present invention generally relates to an aerosol formulation comprising formoterol and beclomethasone dipropionate, said formulation being contained in a coated can, particularly useful for the use in a pressurised metered dose inhaler for the teratment of respiratory diseases.

The present invention generally relates to an aerosol formulation comprising formoterol, beclomethasone dipropionate and glycopyrronium bromide, said formulation being contained in a coated can, particularly useful for the use in a pressurised metered dose inhaler for the treatment of respiratory diseases.

An electronic module for a metered dose inhaler, the electronic module comprising: a housing (10) having an outer surface (17) provided with a pressure detection point (16); an electronic unit (11) and a pressure sensor (13) enclosed in the housing (10). The pressure sensor (13) is operatively connected to the electronic unit (11) and to the pressure detection point (16). The housing (10) comprises two hooks (19) configured to engage an edge (9) of a housing (6) of the metered dose inhaler (2), the housing containing a canister (5) containing the pharmaceutical preparation to be dispensed. A pressure detection point (16) is located between the two hooks (19). The electronics module is attachable to the metered dose inhaler.

The present invention relates to a metered dose inhaler device comprising a stable inhalable composition of ipratropium bromide, contained in a canister fitted with a metering valve, an actuator and a dose indicator. The present invention also relates to a process for preparing such a pharmaceutical composition and its use in the treatment of respiratory disorders such as for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema in a subject in need thereof (e.g., a human).

The present invention generally relates to pharmaceutical composition comprising a LABA agent, optionally in combination with other active ingredients, a chelating agent, a propellant and a co-solvent. The invention also provides a pharmaceutical composition for the treatment of respiratory diseases, such as asthma and COPD.

An assistive device for a metered dose inhaler decreases the force required to operate the inhaler. The assistive device has a body with a passage for receiving a replaceable conventional metered dose inhaler assembly that has a canister and a transverse mouthpiece with an axis of the canister aligning approximately with that of the passage. At least two symmetrically arranged levers extend in a direction away from the body and parallel to an axis thereof. A proximal end of each lever is attached to the body such that the free opposite ends of the levers may be moved towards and away from each other. An inwardly directed cam surface on each of the lever exerts a force on an end of the canister in use to move the canister longitudinally to cause a dose of medicament to be dispensed from the canister. An optional dose counter may form part of the device.

Various embodiments of a metered dose inhaler are disclosed. The inhaler includes a metering valve, a canister, and an actuator having an actuator nozzle. The canister includes a composition having greater than 70% by weight of HFO-1234ze(E), PEG, and at least one active pharmaceutical ingredient suspended in the composition to form a suspension. The compositions are substantially free of ethanol.

1. The name of the design product: dosing device. 2. The use of the design product: for matching with metered dose inhaler, for use when the inhalation medicine is used immediately after spraying. 3. The design points of the design product: in shape. 4. The picture or photo that best shows the design points: design 1 perspective view. 5. Design 1 is designated as the basic design.